Last updated: July 17, 2026

Application No. 18/009,291

Compositions Comprising (Bio)-Alkanediols and Cooling Agents

Non-Final OA

Filed

Dec 08, 2022

Priority

Dec 09, 2020 — EU PCT/EP2020/085168 +1 more

Examiner

VIGIL, TORIANA NICHOLE

Art Unit

1612

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Symrise AG

OA Round

3 (Non-Final)

This examiner grants 52% of cases after interview

— +19.2% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 52 resolved cases, 2023–2026

Examiner Intelligence

VIGIL, TORIANA NICHOLE View full profile →

Grants 52% of resolved cases

Career Allowance Rate

27 granted / 52 resolved

-8.1% vs TC avg

Strong +19% interview lift

Without

With

+19.2%

Interview Lift

resolved cases with interview

Typical timeline

3y 2m

Avg Prosecution

36 currently pending

Career history

106

Total Applications

across all art units

Statute-Specific Performance

§103

71.1%

+31.1% vs TC avg

§102

0.4%

-39.6% vs TC avg

§112

1.6%

-38.4% vs TC avg

Black line = Tech Center average estimate • Based on career data from 52 resolved cases

Prosecution Timeline

Dec 08, 2022

Application Filed

May 12, 2025

Non-Final Rejection mailed

Oct 14, 2025

Response Filed

Nov 28, 2025

Final Rejection mailed

Mar 02, 2026

Request for Continued Examination

Mar 02, 2026

Response after Non-Final Action

Mar 09, 2026

Response after Non-Final Action

Jun 29, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/264,367

Patent 12667100

COMPOSITION COMPRISING BENZYLAMINE ACARICIDE AND USE THEREOF

2y 11m to grant Granted Jun 30, 2026

18/010,752

Patent 12653191

ACTIVE COMPOUND COMBINATIONS

3y 6m to grant Granted Jun 16, 2026

18/161,356

Patent 12655070

STABLE MICRONUTRIENT COMPLEX FOR USE IN AGRICULTURAL APPLICATIONS

3y 4m to grant Granted Jun 16, 2026

18/200,812

Patent 12653838

METHODS OF OTOPROTECTION AGAINST PLATINUM-BASED ANTINEOPLASTIC AGENTS

3y 0m to grant Granted Jun 16, 2026

17/274,850

Patent 12629354

SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING OF A SEDATIVE DRUG AND USES THEREOF

5y 2m to grant Granted May 19, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4

Expected OA Rounds

52%

Grant Probability

71%

With Interview (+19.2%)

3y 2m (~0m remaining)

Median Time to Grant

High

PTA Risk

Based on 52 resolved cases by this examiner. Grant probability derived from career allowance rate.